anti-cancer

A unique collection of 10240 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2760 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3660 drugs with anti-cancer activity or potential anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1920 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of 4270 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1440 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening;

A unique collection of 800 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening;

A unique collection of 536 flavonoids can be used for high throughput and high content screening;

A unique collection of 659 natural terpenes and terpenoids can be used for high throughput and high content screening;

A unique collection of 1812 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3011 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism;

891 peptides can be used in peptide drug development and signaling transduction and mechanism study;

120 well-chosen unique AMPK-targeted small molecules;

A unique collection of 2240 compounds with anti-lung cancer therapeutic activity or targeting lung cancer's major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study;

A unique collection of 2440 compounds with anti-breast cancer therapeutic activity or targeting breast cancer's major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study;

A unique collection of 2508 pancreatic cancer related compounds can be used in HTS and HCS;

2000 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.

1880 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.

2256 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.

A unique collection of 2232 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of 2010 small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of 1470 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;